Cargando…
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections
The recently identified SARS-CoV-2 betacoronavirus responsible for the COVID-19 pandemic has uncovered the age-associated vulnerability in the burden of disease and put aging research in the spotlight. The limited data available indicates that COVID-19 should be referred to as a gerolavic (from Gree...
Autor principal: | Zhavoronkov, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202545/ https://www.ncbi.nlm.nih.gov/pubmed/32229705 http://dx.doi.org/10.18632/aging.102988 |
Ejemplares similares
-
Evaluation of the geroprotective effects of withaferin A in Drosophila melanogaster
por: Koval, Liubov, et al.
Publicado: (2021) -
Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs
por: Zhavoronkov, Alex, et al.
Publicado: (2014) -
The Evaluation of Geroprotective Effects of Selected Flavonoids in Drosophila melanogaster and Caenorhabditis elegans
por: Lashmanova, Ekaterina, et al.
Publicado: (2017) -
Metformin and the promise of geroprotection
por: Kalra, Sanjay, et al.
Publicado: (2012) -
Geroprotection: A promising future
por: Magon, Navneet, et al.
Publicado: (2012)